SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-057030
Filing Date
2017-11-08
Accepted
2017-11-08 08:01:11
Documents
57
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tv477771_10q.htm 10-Q 444390
2 EXHIBIT 31.1 tv477771_ex31-1.htm EX-31.1 9558
3 EXHIBIT 31.2 tv477771_ex31-2.htm EX-31.2 9629
4 EXHIBIT 32.1 tv477771_ex32-1.htm EX-32.1 3479
5 EXHIBIT 32.2 tv477771_ex32-2.htm EX-32.2 3457
  Complete submission text file 0001144204-17-057030.txt   3701017

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT lpcn-20170930.xml EX-101.INS 929563
7 XBRL TAXONOMY EXTENSION SCHEMA lpcn-20170930.xsd EX-101.SCH 27775
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lpcn-20170930_cal.xml EX-101.CAL 28012
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lpcn-20170930_def.xml EX-101.DEF 202580
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE lpcn-20170930_lab.xml EX-101.LAB 246555
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lpcn-20170930_pre.xml EX-101.PRE 232517
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

IRS No.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36357 | Film No.: 171185132
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences